Patents by Inventor Oliver Bernhard

Oliver Bernhard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dendrimer-drug conjugates
    Patent number: 10730999
    Abstract: The present invention generally relates to macromolecules of dendrimer-drug conjugates. In particular, the invention relates to macromolecules comprising a pharmaceutically active agent, such as a protein or peptide, attached to a core of a dendrimer derived from branched building units, such as lysine or lysine analogues. The invention also relates to the synthesis of the dendrimers and macromolecules, and the use of such macromolecules, particularly in therapeutic applications, and pharmaceutical compositions comprising them.
    Type: Grant
    Filed: June 5, 2015
    Date of Patent: August 4, 2020
    Assignee: Starpharma Pty Ltd
    Inventors: David James Owen, Pauline Stanislawski, Michael Giannis, Oliver Bernhard
  • Dendrimer-Drug Conjugates
    Publication number: 20170189543
    Abstract: The present invention generally relates to macromolecules of dendrimer-drug conjugates. In particular, the invention relates to macromolecules comprising a pharmaceutically active agent, such as a protein or peptide, attached to a core of a dendrimer derived from branched building units, such as lysine or lysine analogues. The invention also relates to the synthesis of the dendrimers and macromolecules, and the use of such macromolecules, particularly in therapeutic applications, and pharmaceutical compositions comprising them.
    Type: Application
    Filed: June 5, 2015
    Publication date: July 6, 2017
    Inventors: David James Owen, Pauline Stanislawski, Michael Giannis, Oliver Bernhard